Dr. Savitri Krishnamurthy Presents on Advancing HER2 Interpretation at USCAP 2024

Back

Dr. Savitri Krishnamurthy, a prominent figure at MD Anderson Cancer Center, presented groundbreaking insights on HER2 immunostain interpretation using a computational image analysis approach during her session at the USCAP event. Her talk addressed critical challenges in digital pathology, particularly focusing on the identification of HER2-low cases. Dr. Krishnamurthy highlighted the subjective nature of HER2 interpretation among pathologists and emphasized the potential of AI-driven solutions like Ibex’s platform to enhance consistency and objectivity in scoring. Her research, supported by MD Anderson’s pioneering work, underscores a pivotal shift towards integrating artificial intelligence into routine clinical practice.

Back

About IBEX

IBEX is the leader in AI-powered cancer diagnostics in pathology. We empower physicians to provide every patient with an accurate, timely and personalized cancer diagnosis. Our AI platform is deployed worldwide, supporting pathologists and providers with AI-insights that help improve the quality and accuracy of diagnosis, reduce turnaround times and boost productivity.

By providing my details I agree to the IBEX-AI Terms and conditions and Privacy policy. I also agree to receive emails form IBEX-AI and I understand that I may opt out of IBEX-AI subscriptions at any time.

About IBEX

IBEX is the leader in AI-powered cancer diagnostics in pathology. We empower physicians to provide every patient with an accurate, timely and personalized cancer diagnosis. Our AI platform is deployed worldwide, supporting pathologists and providers with AI-insights that help improve the quality and accuracy of diagnosis, reduce turnaround times and boost productivity.

By providing my details I agree to the IBEX-AI Terms and conditions and Privacy policy. I also agree to receive emails form IBEX-AI and I understand that I may opt out of IBEX-AI subscriptions at any time.

How is artificial intelligence rising to the challenge in breast cancer diagnosis?

How ‘game-changing’ AI is helping discover cancer for the first time in UK | ITV News

The AI revolution in cancer diagnostics with Joseph Mossel, CEO of Ibex Medical Analytics